CareCloud does Revenue Cycle Management (RCM). They make sure U.S. healthcare providers get paid for the care they deliver.
Most U.S. RCMs grow through sales and marketing. They spend about 1.5% of revenue to get 1% more revenue each year. If the company runs at 20% profit margins, that’s a 13% return on investment.
CareCloud trades at 5.7x EV/EBITDA. And its business is better than peers that trade at 3x the price.
By the end of 2025, CareCloud will have $20M in cash. That alone could buy $15M in revenue. With debt and seller financing, they could do a $20–25M deal, adding $6M–10M in EBITDA.
